Emergent colectomy rates decreased while elective ileal pouch rates were stable over time: a nationwide inpatient sample study

go back to reference Fumery M, Singh S, Dulai PS et al (2018) Natural history of adult ulcerative colitis in population-based cohorts: a systematic review. Clin Gastroenterol Hepatol 16(3):343–356CrossRefPubMed Fumery M, Singh S, Dulai PS et al (2018) Natural history of adult ulcerative colitis in population-based cohorts: a systematic review. Clin Gastroenterol Hepatol 16(3):343–356CrossRefPubMed

go back to reference Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF (2017) Ulcerative colitis. Lancet. 389(10080):1756–1770CrossRefPubMed Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF (2017) Ulcerative colitis. Lancet. 389(10080):1756–1770CrossRefPubMed

go back to reference Jarnerot G, Hertervig E, Friis-liby I et al (2005) Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo controlled study. Gastroenterology. 128:1805–1811CrossRefPubMed Jarnerot G, Hertervig E, Friis-liby I et al (2005) Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo controlled study. Gastroenterology. 128:1805–1811CrossRefPubMed

go back to reference Gustavsson A, Jarnerot G, Hertervig E et al (2010) Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study. Aliment Pharmacol Ther 32:984–989CrossRefPubMed Gustavsson A, Jarnerot G, Hertervig E et al (2010) Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study. Aliment Pharmacol Ther 32:984–989CrossRefPubMed

go back to reference Sandborn WJ, Rutgeerts P, Feagan BG, Reinisch W, Olson A, Johanns J, Lu J, Horgan K, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJS, Present D, Sands BE, Colombel JF (2009) Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Gastroenterology. 137:1250–1260 quiz 1520CrossRefPubMed Sandborn WJ, Rutgeerts P, Feagan BG, Reinisch W, Olson A, Johanns J, Lu J, Horgan K, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJS, Present D, Sands BE, Colombel JF (2009) Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Gastroenterology. 137:1250–1260 quiz 1520CrossRefPubMed

go back to reference Aratari A, Papi C, Clemente V, Moretti A, Luchetti R, Koch M, Capurso L, Caprilli R (2008) Colectomy rate in acute severe ulcerative colitis in the infliximab era. Dig Liver Dis 40(10):821–826CrossRefPubMed Aratari A, Papi C, Clemente V, Moretti A, Luchetti R, Koch M, Capurso L, Caprilli R (2008) Colectomy rate in acute severe ulcerative colitis in the infliximab era. Dig Liver Dis 40(10):821–826CrossRefPubMed

go back to reference Kaplan GG, Seow CH, Ghosh S, Molodecky N, Rezaie A, Moran GW, Proulx MC, Hubbard J, MacLean A, Buie D, Panaccione R (2012) Decreasing colectomy rates for ulcerative colitis: a population-based time trend study. Am J Gastroenterol 107(12):1879–1887CrossRefPubMed Kaplan GG, Seow CH, Ghosh S, Molodecky N, Rezaie A, Moran GW, Proulx MC, Hubbard J, MacLean A, Buie D, Panaccione R (2012) Decreasing colectomy rates for ulcerative colitis: a population-based time trend study. Am J Gastroenterol 107(12):1879–1887CrossRefPubMed

go back to reference Reich KM, Chang HJ, Rezaie A, Wang H, Goodman KJ, Kaplan GG, Svenson LW, Lees G, Fedorak RN, Kroeker KI (2014) The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend study. Aliment Pharmacol Ther 40(6):629–638CrossRefPubMed Reich KM, Chang HJ, Rezaie A, Wang H, Goodman KJ, Kaplan GG, Svenson LW, Lees G, Fedorak RN, Kroeker KI (2014) The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend study. Aliment Pharmacol Ther 40(6):629–638CrossRefPubMed

go back to reference Moore Se MGKM, Peterson S et al (2014) Infliximab in ulcerative colitis: the impact of preoperative treatment on rates of colectomy and prescribing practices in the province of British Columbia, Canada. Dis Colon Rectum 57:83–90CrossRefPubMed Moore Se MGKM, Peterson S et al (2014) Infliximab in ulcerative colitis: the impact of preoperative treatment on rates of colectomy and prescribing practices in the province of British Columbia, Canada. Dis Colon Rectum 57:83–90CrossRefPubMed

go back to reference Parragi L, Fournier N, Zeitz J, Scharl M, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L, Swiss IBD Cohort Study Group, Anderegg C, Bauerfeind P, Beglinger C, Begré S, Belli D, Bengoa JM, Biedermann L, Bigler B, Binek J, Blattmann M, Boehm S, Borovicka J, Braegger CP, Brunner N, Bühr P, Burnand B, Burri E, Buyse S, Cremer M, Criblez DH, de Saussure P, Degen L, Delarive J, Doerig C, Dora B, Dorta G, Egger M, Ehmann T, el-Wafa A, Engelmann M, Ezri J, Felley C, Fliegner M, Fournier N, Fraga M, Frei P, Frei R, Fried M, Froehlich F, Funk C, Ivano Furlano R, Gallot-Lavallée S, Geyer M, Girardin M, Golay D, Grandinetti T, Gysi B, Haack H, Haarer J, Helbling B, Hengstler P, Herzog D, Hess C, Heyland K, Hinterleitner T, Hiroz P, Hirschi C, Hruz P, Iwata R, Jost R, Juillerat P, Brondolo VK, Knellwolf C, Knoblauch C, Köhler H, Koller R, Krieger-Grübel C, Kullak-Ublick G, Künzler P, Landolt M, Lange R, Serge Lehmann F, Macpherson A, Maerten P, Maillard MH, Manser C, Manz M, Marbet U, Marx G, Matter C, McLin V, Meier R, Mendanova M, Meyenberger C, Michetti P, Misselwitz B, Moradpour D, Morell B, Mosler P, Mottet C, Müller C, Müller P, Müllhaupt B, Münger-Beyeler C, Musso L, Nagy A, Neagu M, Nichita C, Niess J, Noël N, Nydegger A, Obialo N, Oneta C, Oropesa C, Peter U, Peternac D, Petit LM, Piccoli-Gfeller F, Pilz JB, Pittet V, Raschle N, Rentsch R, Restellini S, Richterich JP, Rihs S, Ritz MA, Roduit J, Rogler D, Rogler G, Rossel JB, Sagmeister M, Saner G, Sauter B, Sawatzki M, Schäppi M, Scharl M, Schelling M, Schibli S, Schlauri H, Uebelhart SS, Schnegg JF, Schoepfer A, Seibold F, Seirafi M, Semadeni GM, Semela D, Senning A, Sidler M, Sokollik C, Spalinger J, Spangenberger H, Stadler P, Steuerwald M, Straumann A, Straumann-Funk B, Sulz M, Thorens J, Tiedemann S, Tutuian R, Vavricka S, Viani F, Vögtlin J, von Känel R, Vonlaufen A, Vouillamoz D, Vulliamy R, Wermuth J, Werner H, Wiesel P, Wiest R, Wylie T, Zeitz J, Zimmermann D (2018) Colectomy rates in ulcerative colitis are low and decreasing: 10 year follow-up data from the Swiss IBD cohort study. J Crohns Colitis 12(7):811–818CrossRefPubMed Parragi L, Fournier N, Zeitz J, Scharl M, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L, Swiss IBD Cohort Study Group, Anderegg C, Bauerfeind P, Beglinger C, Begré S, Belli D, Bengoa JM, Biedermann L, Bigler B, Binek J, Blattmann M, Boehm S, Borovicka J, Braegger CP, Brunner N, Bühr P, Burnand B, Burri E, Buyse S, Cremer M, Criblez DH, de Saussure P, Degen L, Delarive J, Doerig C, Dora B, Dorta G, Egger M, Ehmann T, el-Wafa A, Engelmann M, Ezri J, Felley C, Fliegner M, Fournier N, Fraga M, Frei P, Frei R, Fried M, Froehlich F, Funk C, Ivano Furlano R, Gallot-Lavallée S, Geyer M, Girardin M, Golay D, Grandinetti T, Gysi B, Haack H, Haarer J, Helbling B, Hengstler P, Herzog D, Hess C, Heyland K, Hinterleitner T, Hiroz P, Hirschi C, Hruz P, Iwata R, Jost R, Juillerat P, Brondolo VK, Knellwolf C, Knoblauch C, Köhler H, Koller R, Krieger-Grübel C, Kullak-Ublick G, Künzler P, Landolt M, Lange R, Serge Lehmann F, Macpherson A, Maerten P, Maillard MH, Manser C, Manz M, Marbet U, Marx G, Matter C, McLin V, Meier R, Mendanova M, Meyenberger C, Michetti P, Misselwitz B, Moradpour D, Morell B, Mosler P, Mottet C, Müller C, Müller P, Müllhaupt B, Münger-Beyeler C, Musso L, Nagy A, Neagu M, Nichita C, Niess J, Noël N, Nydegger A, Obialo N, Oneta C, Oropesa C, Peter U, Peternac D, Petit LM, Piccoli-Gfeller F, Pilz JB, Pittet V, Raschle N, Rentsch R, Restellini S, Richterich JP, Rihs S, Ritz MA, Roduit J, Rogler D, Rogler G, Rossel JB, Sagmeister M, Saner G, Sauter B, Sawatzki M, Schäppi M, Scharl M, Schelling M, Schibli S, Schlauri H, Uebelhart SS, Schnegg JF, Schoepfer A, Seibold F, Seirafi M, Semadeni GM, Semela D, Senning A, Sidler M, Sokollik C, Spalinger J, Spangenberger H, Stadler P, Steuerwald M, Straumann A, Straumann-Funk B, Sulz M, Thorens J, Tiedemann S, Tutuian R, Vavricka S, Viani F, Vögtlin J, von Känel R, Vonlaufen A, Vouillamoz D, Vulliamy R, Wermuth J, Werner H, Wiesel P, Wiest R, Wylie T, Zeitz J, Zimmermann D (2018) Colectomy rates in ulcerative colitis are low and decreasing: 10 year follow-up data from the Swiss IBD cohort study. J Crohns Colitis 12(7):811–818CrossRefPubMed

go back to reference Kin C (2017) Bundorf M. as infliximab use for ulcerative colitis has increased, so has the rate of surgical resection. J Gastrointest Surg 21(7):1159–1165CrossRefPubMed Kin C (2017) Bundorf M. as infliximab use for ulcerative colitis has increased, so has the rate of surgical resection. J Gastrointest Surg 21(7):1159–1165CrossRefPubMed

go back to reference Geltzeiler CB, Lu KC, Diggs BS, Deveney KE, Keyashian K, Herzig DO, Tsikitis VL (2014) Initial surgical management of ulcerative colitis in the biologic era. Dis Colon Rectum 57(12):1358–1363CrossRefPubMed Geltzeiler CB, Lu KC, Diggs BS, Deveney KE, Keyashian K, Herzig DO, Tsikitis VL (2014) Initial surgical management of ulcerative colitis in the biologic era. Dis Colon Rectum 57(12):1358–1363CrossRefPubMed

go back to reference Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project (2018) Introduction to the HCUP National Inpatient Sample (NIS). HCUP Central Distributor Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project (2018) Introduction to the HCUP National Inpatient Sample (NIS). HCUP Central Distributor

go back to reference Poojary P, Saha A, Chauhan K et al (2017) Predictors of hospital readmissions for ulcerative colitis in the United States: a National Database Study. Inflamm Bowel Dis 23(3):347–356PubMedPubMedCentral Poojary P, Saha A, Chauhan K et al (2017) Predictors of hospital readmissions for ulcerative colitis in the United States: a National Database Study. Inflamm Bowel Dis 23(3):347–356PubMedPubMedCentral

go back to reference Baram D, Daroowalla F, Garcia R et al (2008) Use of the all patient refined-diagnosis related group (APR-DRG) risk of mortality score as a severity adjustor in the medical ICU. Clin Med Circ Respir Pulm Med 2:19–25 Baram D, Daroowalla F, Garcia R et al (2008) Use of the all patient refined-diagnosis related group (APR-DRG) risk of mortality score as a severity adjustor in the medical ICU. Clin Med Circ Respir Pulm Med 2:19–25

go back to reference Sedman AB, Bahl V, Bunting E et al (2004) Clinical redesign using all patient refined diagnosis related groups. Pediatrics. 114(4):965–969CrossRefPubMed Sedman AB, Bahl V, Bunting E et al (2004) Clinical redesign using all patient refined diagnosis related groups. Pediatrics. 114(4):965–969CrossRefPubMed

go back to reference Kim H-J, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19(3):335–351CrossRefPubMed Kim H-J, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19(3):335–351CrossRefPubMed

go back to reference Yu H, Maclasaac D, Wong JJ et al (2018) Market share and costs of biologic therapies for inflammatory bowel disease in the USA. Aliment Pharmacol Ther 47(3):364–370CrossRefPubMed Yu H, Maclasaac D, Wong JJ et al (2018) Market share and costs of biologic therapies for inflammatory bowel disease in the USA. Aliment Pharmacol Ther 47(3):364–370CrossRefPubMed

go back to reference Gibson DJ, Heetun ZS, Redmond CE, Nanda KS, Keegan D, Byrne K, Mulcahy HE, Cullen G, Doherty GA (2015) An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis. Clin Gastroenterol Hepatol 13(2):330–335.e1CrossRefPubMed Gibson DJ, Heetun ZS, Redmond CE, Nanda KS, Keegan D, Byrne K, Mulcahy HE, Cullen G, Doherty GA (2015) An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis. Clin Gastroenterol Hepatol 13(2):330–335.e1CrossRefPubMed

go back to reference Nguyen GC, Torres EA, Regueiro M, Bromfield G, Bitton A, Stempak J, Dassopoulos T, Schumm P, Gregory FJ, Griffiths AM, Hanauer SB, Hanson J, Harris ML, Kane SV, Orkwis HK, Lahaie R, Oliva-Hemker M, Pare P, Wild GE, Rioux JD, Yang H, Duerr RH, Cho JH, Steinhart AH, Brant SR, Silverberg MS (2006) Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic whites: characterization of a large north American cohort. Am J Gastroenterol 101:1012–1023CrossRef Nguyen GC, Torres EA, Regueiro M, Bromfield G, Bitton A, Stempak J, Dassopoulos T, Schumm P, Gregory FJ, Griffiths AM, Hanauer SB, Hanson J, Harris ML, Kane SV, Orkwis HK, Lahaie R, Oliva-Hemker M, Pare P, Wild GE, Rioux JD, Yang H, Duerr RH, Cho JH, Steinhart AH, Brant SR, Silverberg MS (2006) Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic whites: characterization of a large north American cohort. Am J Gastroenterol 101:1012–1023CrossRef

go back to reference Flasar MH, Quezada S, Bijpuria P, Cross RK (2008) Racial differences in disease extent and severity in patients with ulcerative colitis: a retrospective cohort study. Dig Dis Sci 53:2754–2760CrossRefPubMed Flasar MH, Quezada S, Bijpuria P, Cross RK (2008) Racial differences in disease extent and severity in patients with ulcerative colitis: a retrospective cohort study. Dig Dis Sci 53:2754–2760CrossRefPubMed

go back to reference Sofia MA, Rubin DT, Hou N, Pekow J (2014) Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital. Dig Dis Sci 59:2228–2235CrossRefPubMedPubMedCentral Sofia MA, Rubin DT, Hou N, Pekow J (2014) Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital. Dig Dis Sci 59:2228–2235CrossRefPubMedPubMedCentral

go back to reference Li D, Collins B, Velayos FS, Liu L, Lewis JD, Allison JE, Flowers NT, Hutfless S, Abramson O, Herrinton LJ (2014) Racial and ethnic differences in health care utilization and outcomes among ulcerative colitis patients in an integrated health-care organization. Dig Dis Sci 59:287–294CrossRefPubMed Li D, Collins B, Velayos FS, Liu L, Lewis JD, Allison JE, Flowers NT, Hutfless S, Abramson O, Herrinton LJ (2014) Racial and ethnic differences in health care utilization and outcomes among ulcerative colitis patients in an integrated health-care organization. Dig Dis Sci 59:287–294CrossRefPubMed

go back to reference Nguyen G, Laveist T, Gearhart S et al (2006) Racial and geographic variations in colectomy rates among hospitalized ulcerative colitis patients. Clin Gastroenterol Hepatol 4:1507–1513CrossRefPubMed Nguyen G, Laveist T, Gearhart S et al (2006) Racial and geographic variations in colectomy rates among hospitalized ulcerative colitis patients. Clin Gastroenterol Hepatol 4:1507–1513CrossRefPubMed

go back to reference Nguyen GC, Bayless TM, Powe NR, LaVeist TA, Brant SR (2007) Race and health insurance are predictors of hospitalized Crohn’s disease patients undergoing bowel resection. Inflamm Bowel Dis 13:1408–1416CrossRefPubMed Nguyen GC, Bayless TM, Powe NR, LaVeist TA, Brant SR (2007) Race and health insurance are predictors of hospitalized Crohn’s disease patients undergoing bowel resection. Inflamm Bowel Dis 13:1408–1416CrossRefPubMed

go back to reference Collins KS, Hall A, Neuhaus CU (1999) S. Minority health: a chartbook. Commonwealth Fund, New York Collins KS, Hall A, Neuhaus CU (1999) S. Minority health: a chartbook. Commonwealth Fund, New York

go back to reference Betancourt JR, Green AR, Carrillo JE, Ananeh-Firempong O II (2003) Defining culture competence: a practical framework for addressing racial/ethnic disparitis in health and health care. Public Health Rep 118(4):293–302CrossRefPubMedPubMedCentral Betancourt JR, Green AR, Carrillo JE, Ananeh-Firempong O II (2003) Defining culture competence: a practical framework for addressing racial/ethnic disparitis in health and health care. Public Health Rep 118(4):293–302CrossRefPubMedPubMedCentral

go back to reference Ayanian JZ, Cleary PD, Weissman JS, Epstein AM (1999) The effect of patients’ preferences on racial differences in access to renal transplantation. N Engl J Med 341(22):1661–1669CrossRefPubMed Ayanian JZ, Cleary PD, Weissman JS, Epstein AM (1999) The effect of patients’ preferences on racial differences in access to renal transplantation. N Engl J Med 341(22):1661–1669CrossRefPubMed

go back to reference Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG (2012) Increasing incidence and prevalence of inflammatory bowel diseases with time, based on a systematic review. Gastroenterology. 142:46–54CrossRefPubMed Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG (2012) Increasing incidence and prevalence of inflammatory bowel diseases with time, based on a systematic review. Gastroenterology. 142:46–54CrossRefPubMed

go back to reference Afzali A, Cross RK (2016) Racial and ethnic minorities with inflammatory bowel disease in the United States: a systematic review of disease characteristics and differences. Inflamm Bowel Dis 22(8):2023–2040CrossRefPubMed Afzali A, Cross RK (2016) Racial and ethnic minorities with inflammatory bowel disease in the United States: a systematic review of disease characteristics and differences. Inflamm Bowel Dis 22(8):2023–2040CrossRefPubMed